Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort studyBelén Gutiérrez‐Gutiérrez, Mario Fernández‐Ruiz, Spyros Pournaras et al.|The Lancet Infectious Diseases|2017Cited by 521
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by<i>Klebsiella pneumoniae</i>Carbapenemase–producing<i>K. pneumoniae</i>Mario Tumbarello, Pierluigi Viale, Enrico Maria Trecarichi et al.|Clinical Infectious Diseases|2018Cited by 351
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter StudyMario Tumbarello, Pierluigi Viale, Francesca Raffaelli et al.|Clinical Infectious Diseases|2021Cited by 264
Mortality Attributable to Bloodstream Infections Caused by Different Carbapenem-Resistant Gram-Negative Bacilli: Results From a Nationwide Study in Italy (ALARICO Network)Marco Falcone, Donatella Palazzo, Giusy Tiseo et al.|Clinical Infectious Diseases|2023Cited by 156
Microvascular Effects of Heart Rate Control With Esmolol in Patients With Septic ShockAndrea Morelli, Mervyn Singer, Abele Donati et al.|Critical Care Medicine|2013Cited by 114